Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R

被引:14
|
作者
Zhang, Zuojun [1 ]
Zhao, Ming [1 ]
Wang, Guojie [1 ]
机构
[1] Luoyang Orthoped Hosp Henan Prov, Upper Limb Injury Treatment Ctr, Orthoped Hosp Henan Prov, Luoyang 471002, Peoples R China
关键词
growth; IGF1R; invasion; lung metastasis; metastasis; microRNA-7; osteosarcoma; promoter methylation; FACTOR RECEPTOR; TUMOR-SUPPRESSOR; MIGRATION; INSULIN; PROLIFERATION; EXPRESSION; INVASION; CANCER; APOPTOSIS;
D O I
10.1002/jcp.28787
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We aim to uncover the methylation of microRNA-7 (miR-7) promoter in osteosarcoma (OS) and the inner mechanism of miR-7 on the progression of OS cells. Expression and methylation state of miR-7 in OS tissues and cells were detected. With the aim to unearth the ability of miR-7 in OS, the proliferation, cell cycle progression, apoptosis, invasion, migration of OS cells, and the tumor growth in nude mice were determined. Meanwhile, IGF1R expression was detected and the association between miR-7 and IGF1R was confirmed. The proliferating cell nuclear antigen (PCNA) expression was tested by immunohistochemical staining, and the lung metastasis was observed by H&E staining. miR-7 expression was decreased and methylation state of miR-7 was increased in OS tissues and cells. Upregulated miR-7 inhibited proliferation, cell cycle progression, invasion,and migration, while inducing apoptosis of OS cells and the tumor growth as well as PCNA expression in nude mice. Expression of IGF1R was downregulated in OS cells with overexpression of miR-7. Experiments verified the binding site between miR-7 and IGF1R. Our study demonstrates that abnormal methylation of miR-7 contributes to decreased miR-7 in OS. In addition, miR-7 represses the initiation and progression of OS cells through the inhibition of IGF1R.
引用
收藏
页码:22195 / 22206
页数:12
相关论文
共 50 条
  • [31] Inhibition of the insulin-like growth factor 1 receptor (IGF1R) induces cell cycle arrest and apoptosis in Wilms tumor cells
    Bielen, Aleksandra
    Perryman, Lara
    Hoffman, Francesco
    Pritchard-Jones, Kathy
    Jones, Chris
    CANCER RESEARCH, 2009, 69
  • [32] Let-7b acts as a tumor suppressor in osteosarcoma via targeting IGF1R
    Zhang, Kai
    Wang, Weiwei
    Liu, Yi
    Guo, Aijun
    Yang, Donghui
    ONCOLOGY LETTERS, 2019, 17 (02) : 1646 - 1654
  • [33] Sequencing of type I IGF receptor (IGF1R) inhibition affects chemotherapy response in vitro and in vivo
    Zeng, X.
    Sachdev, D.
    Zhang, H.
    Yee, D.
    CANCER RESEARCH, 2009, 69 (02) : 238S - 238S
  • [34] Combined inhibition of IGF1R and EGFR signaling overcomes the resistance to 3rd-generation EGFR kinase inhibitors caused by IGF1R activation
    Lee, J. C.
    Park, S.
    Rho, J. K.
    Choi, Y. J.
    Choi, C. M.
    Park, J. H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S1 - S1
  • [35] SY-707, an ALK/FAK/IGF1R inhibitor, suppresses growth and metastasis of breast cancer cells
    Liu, Ping
    Sun, Yinghui
    Liu, Shuang
    Niu, Jing
    Liu, Xijie
    Chu, Qiaoyun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (02) : 252 - 260
  • [36] Combined Inhibition of BCR and IGF1R Signaling Leads to Synergistic Apoptosis Induction in Primary CLL Cells in Vitro
    Schmidt-Salzmann, Charlotte
    Yaktapour, Niuscha
    Brummer, Tilman
    Zirlik, Katja
    Claus, Rainer
    BLOOD, 2015, 126 (23)
  • [37] Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
    Browne, B. C.
    Crown, J.
    Venkatesan, N.
    Duffy, M. J.
    Clynes, M.
    Slamon, D.
    O'Donovan, N.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 68 - 73
  • [38] An IGF1R Antibody Does Not Inhibit Growth of Tamoxifen Resistant MCF-7 Cells.
    Fagan, D. H.
    Yee, D.
    CANCER RESEARCH, 2011, 71
  • [39] Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma
    Xu, Lieyu
    Qi, Yicheng
    Xu, Yunze
    Lian, Jianpo
    Wang, Xiaojing
    Ning, Guang
    Wang, Weiqing
    Zhu, Yu
    ONCOTARGET, 2016, 7 (24) : 36235 - 36246
  • [40] IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer
    Somri-Gannam, Lina
    Meisel-Sharon, Shilhav
    Hantisteanu, Shay
    Groisman, Gabriel
    Limonad, Ofer
    Hallak, Mordechai
    Bruchim, Ilan
    TRANSLATIONAL ONCOLOGY, 2020, 13 (08):